Mei Xia

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo”.

Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad441

N/A

0.390DataRank · unranked

9 citations

Rachel L. Edwards, Mei Xia, Christopher S. Eickhoff, Fahreta Hamzabegovic, Krystal A. Meza +20 more

Impact of BCG vaccination on the repertoire of human γδ T cell receptors

Frontiers in Immunology(2023)10.3389/fimmu.2023.1100490

N/A

0.255DataRank · unranked

4 citations

Azra Blazevic, Andrew Fioré-Gartland, Daniel F. Hoft, Mei Xia

Granzyme A Produced by γ9δ2 T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic Activity

Frontiers in Immunology(2021)10.3389/fimmu.2021.712678

N/A

0DataRank · unranked

17 citations

David C. Wood, Christopher S. Eickhoff, Mei Xia, Nicola Pozzi, Rachel L. Edwards +4 more